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Particulate matter (PM) from air pollution is 
associated with cardiovascular morbidity and 
mortality (Bhatnagar 2006; Brook et al. 2003; 
Dockery et al. 1993). These associations are 
strongest for fine PM [aerodynamic diam-
eter ≤ 2.5 µm (PM2.5)] (Miller et al. 2007; 
Samet et al. 2000), probably due to their 
large reactive surface area and their potential 
to penetrate deep into the lung (MacNee and 
Donaldson 2000). Diesel exhaust emissions 
are the major source of PM2.5 in urban envi-
ronments, and although they contribute little 
to the mass of ambient PM, they produce a 
huge burden in terms of particle numbers 
(Laden et al. 2000; Peters et al. 1997).
Despite the strength of these epidemio-
logic associations, the mechanism by which 
inhaled diesel exhaust particulate (DEP) 
exerts cardiovascular effects remains to be 
fully elucidated. In vivo and ex vivo expo-
sures of animals to a range of environmental 
and model particles impair vasodilator func-
tion (Bagate et al. 2004; Batalha et al. 2002; 
Folkmann et al. 2007; Hansen et al. 2007; 
Nurkiewicz et al. 2006, 2008) and encour-
age the progression of cardiovascular disease 
(Araujo et al. 2008; Sun et al. 2005, 2008; 
Suwa et al. 2002). However, the findings 
from in vitro application of PM to isolated 
vascular tissue have been conflicting, causing 
both relaxation (Cheng and Kang 1999; Ikeda 
et al. 1995; Knaapen et al. 2001) and con-
traction (Li et al. 2005; Tzeng et al. 2003). 
Furthermore, the in vitro effects of PM on 
endothelium-dependent and -independent 
vasodilators [e.g., acetylcholine (ACh) and 
sodium nitroprusside (SNP), respectively] 
have received surprisingly little attention, and 
conclusions are difficult to draw because of 
the diverse range of PM types investigated, 
different tissues employed, and a lack of 
appropriate controls.
We have previously shown that inhalation 
of environmentally relevant concentrations of 
DEP impairs endothelial and fibrinolytic func-
tion in healthy volunteers (Mills et al. 2005; 
Tornqvist et al. 2007) and in patients with sta-
ble coronary heart disease (Mills et al. 2007). 
In healthy volunteers, forearm relaxation to 
both ACh and SNP, but not verapamil, was 
impaired, suggesting that diesel exposure was 
acting through inhibition of the nitric oxide 
(NO) pathway. In blood vessels, particularly 
conduit arteries, NO is a key dilator molecule 
and of considerable importance both in cardio-
vascular physiology and in pathophysiology. 
The selective inhibition of NO-mediated 
relaxation supports proposals that the vas-
cular effects of DEP are caused by increased 
generation of oxygen-centered free radicals 
(Donaldson et al. 2003, 2005; Nel et al. 2001) 
that can scavenge endogenous NO.
In the present study, we aimed to determine 
whether DEP directly inhibits endothelium-
dependent NO-mediated relaxation, reduces 
NO bioavailability, and generates oxygen-
  centered free radicals.
Materials and Methods
Preparation of DEP. We prepared fresh DEP 
suspensions each day (2 mg/mL stock solu-
tion) in Krebs buffer (composition in mM: 
118.4 NaCl, 25 NaHCO3, 11 glucose, 4.7 
KCl, 1.2 MgSO4, 1.2 KH2PO4, 2.5 CaCl2); 
the PM was suspended by vortexing for 1 
min followed by probe sonication (US70; 
Philip Harris Scientific, Lichfield, UK) twice 
for 1 min at 60% power (five cycles), and 
resonicated (U50; Ultrawave, Cardiff, UK) 
for 15 min before use.
We measured mean particle diameter 
by photon correlation spectroscopy using 
a PS90 particle size analyzer (Brookhaven 
Instruments Corp., Holtsville, NY, USA) set 
to the following parameters: 37°C, 90° angle; 
1 min run duration; refractive index of PM: 
1.5, “real,” and 0, “imaginary”; dust cutoff, 
30. We diluted samples 50-fold in Krebs buf-
fer to allow sufficient penetration of laser light 
through the sample.
Vascular tissue preparation and protocol. 
We performed all our experiments accord-
ing to the Animals (Scientific Procedures) 
Act 1986 (U.K. Home Office) to ensure that 
we treated all animals humanely and with 
regard to the alleviation of suffering. Adult 
male Wistar rats (250–400 g) were killed by 
cervical dislocation and the thoracic aorta 
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Ba c k g r o u n d: Diesel exhaust particulate (DEP) is a key arbiter of the adverse cardiovascular effects 
of air pollution. 
oBjectives: We assessed the in vitro effects of DEP on vascular function, nitric oxide (NO) avail-
ability, and the generation of oxygen-centered free radicals. 
Me t h o d s : We assessed the direct vascular effects of DEP (10–100 µg/mL) in isolated rat aortic 
rings using myography. We investigated NO scavenging and oxygen-centered free radical gen-
eration using an NO electrode and electron paramagnetic resonance (EPR) with the Tempone-H 
(1-hydroxyl-2,2,6,6-tetramethyl-4-oxo-piperidine) spin trap, respectively. 
re s u l t s: Acetylcholine-induced relaxation was attenuated by DEP (maximum relaxation reduced 
from 91 ± 4% to 49 ± 6% with 100 µg/mL DEP; p < 0.001) but was restored by superoxide dis-
mutase (SOD; maximum relaxation, 73 ± 6%; p < 0.001). DEP caused a modest inhibition of 
relaxation to NO donor drugs, an effect that could be reversed by SOD (p < 0.01). At 10 µg/mL, 
DEP did not affect verapamil-induced relaxation (p = 0.73), but at 100 µg/mL DEP inhibited relax-
ation (p < 0.001) by a mechanism independent of SOD. NO concentrations generated by 2-(N,N-
diethylamino)-diazenolate-2-oxide (DEA/NO; 10 µM) were reduced by DEP (100 µg/mL; from 
5.2 ± 0.4 to 3.3 ± 0.4 µM; p = 0.002). Free radical generation was increased by DEP (10 µg/mL; 
9-fold increase in EPR spectra; p = 0.004) in a manner that could be attenuated by SOD (p = 0.015). 
co n c l u s i o n s: DEP caused oxidative stress through the generation of oxygen-centered free radicals 
that reduced the bioavailability of endothelium-derived NO without prior interaction with the lung 
or vascular tissue. These findings provide a mechanism for the adverse cardiovascular effects of par-
ticulate air pollution.
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was dissected free. We cleaned segments 
(~5 mm length) of connective tissue and 
mounted them in a multimyograph system 
(610M; Danish Myo Technology, Aarhus, 
Denmark) in Krebs buffer bubbled with 5% 
CO2/95% O2 at 37°C. A baseline tension of 
14.7 mN was gradually applied over 10 min 
and vessels were allowed to equilibrate for 
a further 30 min. Preliminary experiments 
showed that this tension produced optimal 
contraction and relaxation responses. The 
data from force transducers were processed by 
a MacLab/4e analogue-digital converter dis-
played through Chart software, version 3.4.3 
(AD Instruments, Sussex, UK).
We confirmed vessel viability by a con-
tractile response on addition of 80 mM KCl, 
repeated three times, and then obtained con-
centration–response curves to phenylephrine 
(PE; 1 nM to 10 µM) and selected a concen-
tration that produced 80% maximum con-
traction (EC80; 0.1–1 µM) for each individual 
rat aortic ring. After contraction, we obtained 
cumulative concentration–response curves 
for ACh (endothelium-dependent vasodila-
tor; 1 nM to 10 µM), SNP (endothelium-
independent NO donor; 0.1 nM to 1 µM), 
and the calcium channel antagonist verapamil 
(endothelium- and NO-independent vaso-
dilator; 1 nM to 100 µM). We pretreated 
all vessels with DEP (100 µg/mL) and/or 
superoxide dismutase (SOD; 100 U/mL) 20 
min before the start of, and throughout, gen-
eration of concentration–response curves. We 
analyzed these four treatment groups in paral-
lel with aortic rings from the same animal. 
We allowed at least 30 min washout before 
application of subsequent drugs. Addition of 
DEP did not affect the pH or osmolarity of 
the Krebs buffer.
 NO measurement. We measured NO 
electrochemically with an NO electrode 
(ISO-NOP; World Precision Instruments, 
Stevenage, UK) attached to an amplifier (NO 
meter; ISO-NO Mark II; World Precision 
Instruments); the electrode was introduced 
to the cuvette containing 2 mL Krebs buf-
fer with or without DEP (100 µg/mL), pre-
warmed to 37°C and stirred continuously at 
1,000 rpm. Once we obtained a stable baseline 
(10–30 min), we calibrated the electrode using 
2-(N,N-diethylamino)-diazenolate-2-oxide 
(DEA/NO; 100–800 nM) in phosphate buf-
fer at pH 4; DEA/NO undergoes rapid and 
complete spontaneous decomposition at this 
pH (Davies et al. 2001). We used Krebs buffer 
(pH 7.4) for subsequent protocols. We added 
DEP (100 µg/mL) 2 min before addition of 
DEA/NO (10 µM) and measured changes in 
signal for 15 min. Recalibration at the end 
of the experiment revealed no change in sen-
sitivity. Neither the baseline signal from the 
microsensor nor the posttreatment calibration 
to DEA/NO afterward was affected by DEP.
Electron paramagnetic resonance. We 
used electron paramagnetic resonance (EPR) 
to establish oxygen-centered free radical gen-
eration from DEP in the absence of tissue. 
We prepared and incubated solutions with 
the spin trap, 1-hydroxyl-2,2,6,6-tetrame-
thyl-4-oxo-piperidine (Tempone-H; 1 mM), 
immediately before the initial measurement. 
Tempone-H is a highly sensitive spin trap 
that shows selectivity for superoxide, as well 
as peroxyl radicals and peroxynitrite, forming 
a stable product that can be measured by EPR 
(Dikalov et al. 1997). We used pyrogallol 
(100 µM) as a positive control to generate 
superoxide radicals (Taylor et al. 2004). In 
selected samples, we added SOD (100 U/mL) 
as a specific scavenger of superoxide anions.
We ensured that samples were kept at 
37°C throughout and measurements were 
taken after 1, 20, 40, and 60 min by draw-
ing 50 µL of sample into a capillary tube 
(Scientific Laboratory Ltd., Coatbridge, 
UK) and sealing it with a plug of soft sealant 
(Cristaseal, VWR International, Lutterworth, 
UK). We used an X-band EPR spectro- 
meter  (Magnettech  MS-200,  Berlin, 
Germany) with the following parameters: 
microwave frequency, 9.3–9.55 Hz; micro-
wave power, 20 mW; modulation frequency, 
100 kHz; modulation amplitude, 1,500 mG; 
center field, 3,365 G; sweep width, 50 G; 
sweep time, 30 sec; number of passes, 1.
Drugs and reagents. We obtained Krebs 
salts from VWR International, and all other 
drugs from Sigma Ltd. (Poole, UK), with the 
exception of DEA/NO (Alexis Biochemicals, 
Nottingham, UK), Tempone-H (Alexis 
Biochemicals), and DEP [SRM-2975, National 
Institute of Standards and Technology 
(NIST), Gaithersburg, MD, USA]. We dis-
solved and diluted all drugs in Krebs buffer, 
with the exception of Tempone-H [dissolved 
in 0.01 M EDTA (final concentration, 0.1 
mM) to minimize metal-ion–induced auto-
oxidation] and DEA/NO (0.01 M NaOH; 
final concentration, 0.1 mM). Preliminary 
Figure 1. Effect of DEP (10 µg/mL) or vehicle control in the presence (circles) or absence (squares) of SOD 
(100 U/mL) on contraction and relaxation induced by PE (A and B), ACh (C), SNP (D), DEA/NO (E), and vera-
pamil (F). Vessels were precontracted with EC80 PE (0.3–1 µM). Data are mean ± SE (n = 7–8 for all). 
Two-way repeated-measures ANOVA: *p < 0.05, and ***p < 0.001 (ns, not significant), control versus DEP; †p < 0.05, 
††p < 0.01, and †††p < 0.001 (NS, not significant), DEP versus DEP + SOD.
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experiments confirmed that, in all cases, addi-
tion of vehicle alone had no effect on vessel 
tone or NO electrode measurements.
Statistical and data analysis. We express 
all data as mean ± SE, and EPR intensity on 
an arbitrary scale based on the area under the 
curve of the first derivative of the first line of 
the three-line spectrum generated (Taylor et al. 
2004) using Miniscope software (version 6.51; 
Magnettech, Berlin, Germany). We measured 
maximum responses of the NO microsensor 
in millivolts and present them as NO con-
centration (µM) derived from the gradient of 
the calibration curve. We express vasodilator 
responses as a percentage of the precontraction 
to EC80 PE, where positive values represent 
relaxation and 100% relaxation represents a 
complete abolition of PE-induced tone.
We performed statistical comparisons of 
concentration–response curves using two-
way repeated-measures analysis of variance 
(ANOVA). Additionally, we calculated maxi-
mum vasodilator responses (Imax) and IC50 
concentrations (defined as the concentra-
tion of vasodilator required to produce 50% 
relaxation of precontraction tone) following 
linear regression of individual curves [using 
GraphPad Prism version 4.0b (Graphpad 
Software Inc., La Jolla, CA, USA)] and 
made statistical comparisons using one-way 
ANOVA, with Bonferroni post hoc tests of 
selected comparisons where appropriate. We 
carried out statistical comparisons of NO con-
centrations using two-way ANOVA and made 
comparisons of EPR data at 60 min using 
paired t-tests. We considered p < 0.05 to be 
statistically significant.
Results
Effect of DEP on vascular function. Photon 
correlation spectroscopy confirmed that mean 
diameter of DEP aggregates suspended in 
Krebs buffer was < 1 µm (0.94 ± 0.01 µm;   
n = 3). Responses to PE were smaller in the 
presence of 10 µg/mL DEP (p = 0.012, two-
way ANOVA compared with control; n = 7 
for all; Figure 1A), although when expressed as 
a percentage of the maximum contraction, to 
look at changes in sensitivity to PE, we found 
no effect from either concentration of DEP 
(Figures 1B, 2B; Table 1). Consequently, 
EC80 values for PE were similar for DEP- 
and SOD-treated tissues (p = 0.51, one-way 
ANOVA; n = 7 for all).
ACh (1 nM to 10 µM) caused a concen-
tration-dependent relaxation of rat aortic rings. 
The presence of 10 µg/mL DEP produced a 
rightward shift in this response (p < 0.001, two-
way ANOVA; n = 7; Figure 1C), lowering log 
IC50 from –7.31 ± 0.22 to –6.99 ± 0.19 in the 
presence of DEP (p = 0.009, one-way ANOVA; 
n = 7; Table 1). Increasing the concentration 
of DEP to 100 µg/mL markedly inhibited 
ACh-induced relaxation (Figure 2C), with Imax 
reduced from 91 ± 4% to 49 ± 6% (n = 7, 
p < 0.001; Table 1). Coincubation with SOD 
(100 U/mL) completely reversed the inhibitory 
effect of 10 µg/mL DEP (p < 0.001, two-way 
Table 1. Effect of DEP and SOD on aortic ring contraction and relaxation (mean ± SE).
  PE (n = 7)  ACh (n = 7)  SNP (n = 6–7)  DEA/NO (n = 8)  Verapamil (n = 5–7)
  Log EC50  Max. contraction  Log IC50 I max (%)  Log IC50 I max (%)  Log IC50 I max (%)  Log IC50 I max (%)
10 µg/mL DEP
  Control  –7.13 ± 0.14  18.75 ± 2.49  –7.31 ± 0.22  95.5 ± 0.9  –8.33 ± 0.12   98.1 ± 0.9  –7.71 ± 0.11  97.9 ± 0.4  –5.92 ± 0.48   38.3 ± 6.9
  SOD  –7.14 ± 0.10  17.89 ± 1.66  –7.52 ± 0.24  93.9 ± 2.0  –8.22 ± 0.12  100.8 ± 1.1  –7.85 ± 0.05  96.9 ± 0.9  –6.44 ± 0.48   46.8 ± 5.0
  DEP  –7.04 ± 0.13  15.30 ± 2.16  –6.99 ± 0.19*  86.1 ± 2.8**  –8.02 ± 0.12*   97.7 ± 0.3  –7.80 ± 0.16  98.6 ± 0.4  –6.19 ± 0.05    30.0 ± 5.3 
  DEP + SOD  –7.12 ± 0.10  18.21 ± 1.85  –7.41 ± 0.20 ††  91.8 ± 1.7  –8.30 ± 0.11   99.5 ± 0.9  –7.68 ± 0.11  99.0 ± 0.7  –6.08 ± 0.13   42.7 ± 7.3 
100 µg/mL DEP
  Control  –6.88 ± 0.19  19.99 ± 3.18  –7.33 ± 0.08  91.2 ± 3.7  –7.04 ± 0.21  100.0 ± 2.4  –7.48 ± 0.06  97.9 ± 0.3  –6.57 ± 0.25   37.7 ± 5.6
  SOD  –6.90 ± 0.12  20.25 ± 2.47  –7.51 ± 0.17  86.2 ± 3.6  –7.02 ± 0.15   97.0 ± 2.5  –7.62 ± 0.08  95.5 ± 0.7  –6.37 ± 0.12   36.8 ± 5.9
  DEP  –6.84 ± 0.14  17.97 ± 2.66  –6.04 ± 0.16***  48.5 ± 6.2***  –6.52 ± 0.14  101.0 ± 1.4  –7.19 ± 0.06**  97.9 ± 1.1  –5.37 ± 0.06***   28.8 ± 6.1
  DEP + SOD  –6.98 ± 0.07  19.24 ± 1.70  –6.66 ± 0.13††  72.9 ± 6.0†  –7.25 ± 0.60   101.7 ± 2.5  –7.45 ± 0.10†  96.1 ± 1.2  –5.45 ± 0.02   29.6 ± 4.3
*p < 0.05, **p < 0.01, and ***p < 0.001, control versus DEP; †p < 0.05, and ††p < 0.01, DEP versus DEP + SOD, by Bonferroni post hoc test after one-way ANOVA.
Figure 2. Effect of DEP (100 µg/mL; solid symbols) or vehicle control (open symbols) in the presence (cir-
cles) or absence (squares) of SOD (100 U/mL) on contraction and relaxation induced by PE (A and B), ACh 
(C), SNP (D), DEA/NO (E), and verapamil (F). Vessels were precontracted with EC80 PE (0.3–1 µM). Data are 
mean ± SE (n = 6–8 for all). 
Two-way repeated-measures ANOVA: ***p < 0.001 (ns, not significant), control versus DEP; ††p < 0.01, and †††p < 0.001 
(NS, not significant), DEP versus DEP + SOD.
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ANOVA comparing DEP with DEP + SOD; 
n = 7; Figure 1C) and partially reversed that of 
100 µg/mL DEP-induced inhibition of ACh-
mediated relaxation (p < 0.001; Figure 2C), 
with Imax returning to 73 ± 6% (p < 0.001, 
DEP + SOD vs. DEP alone; n = 7; Table 1). 
SOD (100 U/mL) had no effect on ACh-
induced relaxation, or any of the other vaso-
dilators used, in the absence of DEP (p > 0.29, 
two-way ANOVA; n = 6–8 for all).
Both concentrations of DEP (10 and 
100 µg/mL) caused a modest, but consis-
tent, inhibition of SNP-induced relaxation 
(p < 0.001 for both 10 and 100 µg/mL DEP, 
two-way ANOVA; n = 6–7), without reducing 
maximum relaxation (p = 0.08 and p = 0.56, for 
10 and 100 µg/mL DEP, respectively, one-way 
ANOVA; n = 6–7; Table 1). The inhibition 
caused by DEP could be reversed by coincuba-
tion with SOD (p < 0.001 and p = 0.010 for 
10 and 100 µg/mL DEP, respectively, two-way 
ANOVA; Figures 1D, 2D). DEP (100 µg/
mL) also produced a similar modest inhibition 
on relaxation produced by the spontaneous 
NO donor DEA/NO (p < 0.001, two-way 
ANOVA; n = 8) that could be reversed by 
coincubation with SOD (p < 0.001, two-way 
ANOVA; n = 8; Figure 2E, Table 1). DEP had 
no effect on verapamil-induced relaxation at 
10 µg/mL (p = 0.73, two-way ANOVA; n = 7; 
Figure 1F) but caused a rightward shift in the 
concentration–response curve at 100 µg/mL 
DEP (p < 0.001, two-way ANOVAs; n = 5) 
that was unaltered by coincubation with SOD 
(p = 0.20, two-way ANOVA comparing DEP 
with DEP + SOD; n = 5; Figure 2F).
NO scavenging by DEP. In Krebs buffer 
alone, the NO donor DEA/NO (10 µM) 
caused a time-dependent increase in NO 
concentration, reaching a plateau of ~5 µM 
after ~10 min (Figure 3). In the presence 
of 100 µg/mL DEP, there was a decrease in 
the NO concentrations from 5.18 ± 0.38 
to 3.28 ± 0.38 µM (p = 0.002, two-way 
ANOVA, n = 8–10) at 15 min.
Oxygen-centered free radical genera-
tion by DEP. Measurements from control 
samples (spin trap + drug vehicle) showed a 
slow time-dependent increase in the charac-
teristic three-line spectrum for a spin adduct 
with the unpaired electron in the vicinity of 
a nitrogen atom (i.e., 4-oxo-2,2,6,6-tetra-
methyl  piperidine-1-oxyl) formed from auto-
oxidation of Tempone-H (Figure 4A). The 
signal increased at a constant rate over the 
60-min period (Figure 4B). The EPR sig-
nal was enhanced throughout the incuba-
tion period in solutions containing 3 µg/mL 
DEP. EPR intensity was approximately 9-fold 
higher (p = 0.004, paired t-test; n = 6) in 10 
µg/mL DEP suspensions (5,453 ± 577 units) 
than in controls (624 ± 15 units) after 60 min. 
SOD (100 U/mL) inhibited the EPR signal 
from DEP, causing a 39% reduction in signal 
intensity (3,394 ± 131 units; p = 0.015, paired 
t-test; n = 6). SOD caused similar effects on 
signals produced by the superoxide generator 
pyrogallol (35% reduction; p = 0.0015, paired 
t-test; n = 6; Figure 4B).
Discussion
In a comprehensive series of in vitro experi-
ments, we have demonstrated that DEP inhib-
its endothelium-dependent NO-mediated 
relaxation. This reduced relaxation is consis-
tent with the consumption of NO by DEP-
derived oxygen-centered free radicals. These 
effects were demonstrable in the absence of 
tissue and without the need for prior inter-
action with the lung.
The effect of DEP on vascular function. The 
mechanism mediating the apparent causal asso-
ciation between air pollution and cardiovascu-
lar disease has yet to be fully elucidated. The 
traditional view is that inhaled PM provoke an 
inflammatory response in the lung, with sub-
sequent release of prothrombotic and inflam-
matory cytokines into the circulation (Seaton 
et al. 1999). Alternatively, the nanometer 
size of DEP may allow translocation across 
the respiratory epithelium into the circulation 
and directly affect the cardiovascular system 
(reviewed in Oberdorster et al. 2007; Peters 
et al. 2006). We were therefore interested in the 
direct effects of DEP on vascular function.
Surprisingly few studies have looked at the 
effect of PM on vascular tone in isolated blood 
vessels and have generated contradictory data 
that, in part, relate to the differences in PM 
studied. We selected a well-characterized DEP 
supplied from NIST. Our results showed that 
the direct addition of DEP to isolated rat aor-
tic rings markedly attenuated endothelium-
dependent relaxation induced by ACh. We 
hypothesized that this inhibitory effect was 
not confined to the endothelium but would 
also affect responses to exogenous sources of 
NO. Consistent with this hypothesis, DEP 
produced a modest inhibition of vasodilator 
responses to the endothelium-independent NO 
generators SNP and DEA/NO. To explore this 
further, we measured NO release from DEA/
NO using a highly selective NO sensor. In the 
presence of DEP, the levels of NO were mark-
edly decreased, suggesting that DEP scavenges 
NO and thereby reduces its bioavailability.
Of interest is the greater magnitude of 
inhibition of relaxation to ACh compared 
with NO donor drugs. The relatively small 
inhibition of SNP-induced relaxation is not 
necessarily surprising considering the intracel-
lular release of NO from this drug (Bates et al. 
1991; Kowaluk et al. 1992) that will, to some 
extent, protect it from extracellular superoxide. 
However, we observed a similar inhibition of 
relaxation to DEA/NO even though a sub-
stantial proportion of NO release will occur 
extracellularly in solution (Maragos et al. 1991; 
Miller et al. 2004). Thus, although scavenging 
of NO accounts for some of these effects, DEP 
has additional actions on the vasculature that 
may include reduced NO generation or pertur-
bation of other endothelial pathways.
The concentrations of DEP used here 
have few direct cytotoxic effects on endothe-
lial cells (unpublished observations), but they 
may decrease the release of NO or prostaglan-
dins from the endothelium, and endotheli-
um-dependent hyperpolarizing factors in 
other blood vessels. The present study uses 
  large-conductance vessels to specifically explore 
the effect of DEP on the vascular NO pathway. 
Figure 4. Detection of free radicals from DEP (10 µg/mL) using EPR. (A) Sample spectra after 60 min show-
ing the characteristic three-peaked spectrum produced by oxidation of the spin trap Tempone-H (1 mM); 
DEP (10 µg/mL) caused a large increase in peak amplitude, an effect that was partially reduced by coin-
cubation with SOD (100 U/mL). (B) EPR intensity generated by auto-oxidation (control), DEP, or pyrogallol 
(100 µM) over a 1-hr period, in the presence (open symbols) or absence of SOD (solid symbols). EPR 
intensity is calculated using the area under the curve of the first derivative of the first line of the three-line 
spectrum generated. Data are mean ± SE (n = 6). 
Paired t-tests: *p < 0.05, DEP versus DEP + SOD; **p < 0.01, control versus DEP; ††p < 0.01, pyrogallol versus pyrogallol + SOD.
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Figure 3. Nitric oxide concentrations generated 
from the NO donor DEA/NO (10 µM) in the presence 
or absence of DEP (100 µg/mL). Data are mean ± SE 
(n = 8–10). 
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DEP (Hiramatsu et al. 2003; Saito et al. 2002) 
and urban air PM (Chauhan et al. 2004) 
decrease the expression of inducible NO syn-
thase, but it is unlikely that changes in protein 
expression can account for the inhibitory effect 
of DEP after only 20–30 min of incubation. 
A more likely hypothesis is that NO synthase 
activity is altered by DEP, perhaps through 
altered phosphorylation (Sumanasekera et al. 
2007), uncoupling of NO synthase (Knuckles 
et al. 2008), or up-regulation of the endo- 
genous NO synthase inhibitor asymmet-
ric dimethylarginine (Dvonch et al. 2004). 
Interestingly, several quinones, which are com-
mon components of DEP, decrease the activity 
of endothelial NO synthase and inhibit the 
relaxation to ACh, but not SNP (Kumagai 
et al. 2001; Sun et al. 2006). Work is currently 
under way to specifically address which compo-
nents of DEP are responsible for these actions.
Relatively few studies have conducted 
an in-depth exploration of the mechanism 
of action of air pollutants on vascular tone 
through the use of endothelium-dependent 
and -independent vasodilators (Cheng and 
Kang 1999; Hansen et al. 2007; Ikeda 
et al. 1995; Muto et al. 1996; Proctor et al. 
2006; Sun et al. 2006). Of these, only three 
explored the direct effect of DEP on isolated 
blood vessels, and all have been conducted in 
rodents. Similar to our own findings, Ikeda 
et al. (1995) showed that DEP at concentra-
tions > 10 µg/mL inhibited relaxation to ACh 
and, to a lesser extent, to SNP in rat aortic 
rings (Ikeda et al. 1995). These findings have 
been confirmed in rabbit (Muto et al. 1996), 
but not murine (Hansen et al. 2007), aortic 
rings. However, none of these studies used an 
NO-independent vasodilator to ensure that 
alterations in vascular smooth muscle function 
did not underlie the reductions in relaxation. 
Here we show that relaxation induced by the 
calcium channel antagonist verapamil was 
unaffected by 10 µg/mL DEP, a concentra-
tion that inhibited all other vasodilators tested. 
However, at the highest concentration of 
DEP, verapamil-induced relaxation was inhib-
ited by a mechanism that was not reversible by 
SOD. At such high doses, a more profound 
effect on the vasculature may occur and result 
in more widespread tissue effects, including 
vascular smooth muscle dysfunction.
Our data complement those from previous 
in vivo animal studies showing that inhalation 
exposure or pulmonary instillation of environ-
mental and model particles is associated with 
inhibition of endothelium-dependent vasodi-
lators (Bagate et al. 2004; Batalha et al. 2002; 
Nurkiewicz et al. 2004, 2006, 2008; Sun 
et al. 2005). Interestingly, vascular responses 
after controlled exposure of diesel exhaust in 
humans show a profile of action similar to that 
seen in our in vitro study (Mills et al. 2005). 
This similarity suggests the possibility of using 
these combined in vitro techniques to screen 
different PM and manufactured particles.
Free radical generation by DEP. Free rad-
ical generation has been implicated in a wide 
range of environmental and commercial par-
ticles, including asbestos, glass fibers, carbon 
black, coal dust, quartz, titanium dioxide, and 
urban PM (Donaldson et al. 2003). DEP has 
a large reactive surface area and therefore has 
the potential to generate large amounts of free 
radicals via the redox-cycling chemicals on its 
surface. Superoxide is an oxygen-centered free 
radical that reacts extremely rapidly with NO, 
lowering its bioavailability and simultaneously 
producing cytotoxic peroxynitrite. Therefore, 
loss of endogenous NO due to scavenging by 
free radicals represents a potential mechanism 
to link air pollution to the development of 
cardiovascular diseases (Künzli et al. 2005).
An important finding in our study is that 
the adverse vascular effects of DEP can be par-
tially prevented by coincubation with SOD. 
Taken together with the observed reductions in 
NO concentrations, we suggest the inhibitory 
effects of DEP are mediated through the gener-
ation of superoxide radicals that consume NO. 
This is a major potential underlying mech-
anism that links atherosclerosis and cardio- 
vascular disease with air pollution exposure.
PM such as DEP can up-regulate cellular 
pathways associated with free radical produc-
tion (Donaldson et al. 2003, 2005), but few 
studies have looked at the innate ability of DEP 
to generate free radicals itself. The unstable 
nature of most free radicals means that they 
can be quantified only by indirect measures. 
Compared with other measures of free radi-
cals, EPR is a highly sensitive technique and, 
by using a spin trap to stabilize the radical of 
interest, allows measurement of the radical 
itself, with the characteristics of the free electron 
providing the signal. Recent improvements in 
the properties of spin traps have included incor-
poration of fast reaction rates, stability of radi-
cal-trap product, specificity for certain radicals, 
good signal-to-noise ratio, and a spectrum that 
allows for characterization and quantification. 
This has extended the possible applications of 
this technique and is not affected by the col-
ored solutions such as the intense black of high 
concentrations of DEP that can restrict some 
fluorometric or chemiluminescence assays (Aam 
and Fonnum 2007). Previously, the spin trap 
5,5-dimethyl-1-pyrroline-N-oxide (DMPO) 
has been used to demonstrate that DEP gene- 
rates both superoxide and hydroxyl radicals in 
the absence of tissue, whereas methanol-washed 
DEP or pure charcoal produced little in the 
way of radicals (Sagai et al. 1993). DMPO is a 
poor spin trap for the detection of superoxide 
because of its slow reaction rate with this radical 
and because of the difficulty in separating the 
peaks in the spectra produced by superoxide 
from those of hydroxyl radicals.
Here we used the spin trap Tempone-H, 
which is several orders of magnitude more 
sensitive for superoxide than for other free 
radicals (Dikalov et al. 1997). DEP itself gen-
erated high concentrations of free radicals in 
solution. Coincubation with SOD attenuated 
the amplitude of DEP-induced EPR signals 
to a similar extent to radical generation by 
pyrogallol, a compound that generates super-
oxide via auto-oxidation in aqueous solution 
(Marklund and Marklund 1974). The inabil-
ity of SOD to abolish EPR signals suggests 
that SOD may be unable to compete with the 
reaction of superoxide with Tempone-H.
The scavenging of DEP-derived free radi-
cals by SOD complements its ability to reverse 
the inhibitory effect of DEP on NO-mediated 
vascular responses. This is the first time that 
a superoxide-selective spin trap has been used 
to clarify the free radicals generated by DEP. 
The results highlight the innate potential of 
these particles to generate oxygen-centered free 
radicals. Importantly, these results show that 
combustion-derived nanoparticles do not nec-
essarily require the recruitment of inflamma-
tory cells from the lung to cause oxidative stress 
and damage.
Limitations. We have shown that DEP can 
directly impair vascular function without prior 
interaction with lung tissue. PM can cross bar-
riers into the brain or circulation (Berry et al. 
1977; Chen et al. 2006; Kreyling et al. 2002; 
Kwon et al. 2008; Nemmar et al. 2001, 2002; 
Oberdorster et al. 2002; Takenaka et al. 2001) 
and may directly interact with vascular tis-
sue to cause effects similar to those described 
here. However, we acknowledge that we have 
employed high in vitro concentrations to 
achieve these effects, and it is unclear how such 
observations relate to the anticipated expo-
sure derived from the inhalation of ambient 
air pollution. Conversely, in vitro effects may 
underestimate free-radical–initiated actions 
due to the absence of oxidative stress amplifi-
cation by inflammatory cells, or the depletion 
of antioxidant defenses associated with cardio-
vascular disease. Nevertheless, the similarity 
of our in vitro findings with those of clinical 
exposure studies (Mills et al. 2005; Tornqvist 
et al. 2007) suggests that, despite the necessity 
for high particle concentrations, these tech-
niques are predictive of their cardiovascular 
toxicology. The use of these in vitro techniques 
could provide an initial step to determine the 
cardiovascular toxicity and potency of differ-
ent environmental and engineered PM as well 
as the effects of fuel modification and particle 
trap technology.
Conclusions
DEP directly inhibits vascular relaxation to 
endothelium-dependent vasodilators through 
the consumption of NO by oxygen-centered 
free radicals, such as superoxide. These results Miller et al.
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demonstrate the innate ability of the PM in 
air pollution to impair vascular function and 
highlight the need to identify the toxic com-
ponents of combustion-derived nanoparticles.
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